Evogene (EVGN) FCF Margin (QoQ) (2013 - 2026)
Evogene (EVGN) FCF Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,033.00 |
| Dec 31, 2025 | -81,344.00 |
| Sep 30, 2025 | 22,147.00 |
| Jun 30, 2025 | -4,553.00 |
| Mar 31, 2025 | 5,872.00 |
| Dec 31, 2024 | 1,010.00 |
| Sep 30, 2024 | -118,400.00 |
| Jun 30, 2024 | 79,772.00 |
| Mar 31, 2024 | -90,875.00 |
| Dec 31, 2023 | 113,054.00 |
| Sep 30, 2023 | 63,915.00 |
| Jun 30, 2023 | -173,764.00 |
| Mar 31, 2023 | 135,028.00 |
| Dec 31, 2022 | 109,376.00 |
| Sep 30, 2022 | 57,034.00 |
| Jun 30, 2022 | -510,162.00 |
| Mar 31, 2022 | 574,772.00 |
| Dec 31, 2021 | 104,616.00 |
| Sep 30, 2021 | -843,885.00 |
| Jun 30, 2021 | 606,352.00 |